(Q45888910)

17 December 2017

title

Cost-utility analysis of primary prophylaxis versus treatment on-demand for individuals with severe haemophilia (English)

1 reference

17 December 2017

author

Caroline Sabin

2

1 reference

17 December 2017

author name string

Alexander H Miners

1

1 reference

17 December 2017

Keith H Tolley

3

1 reference

17 December 2017

Christine A Lee

4

1 reference

17 December 2017

publication date

1 January 2002

1 reference

17 December 2017

published in

PharmacoEconomics

1 reference

17 December 2017

volume

20

1 reference

17 December 2017

issue

11

1 reference

17 December 2017

page(s)

759-774

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.2165/00019053-200220110-00005

exact match

0 references

cites work

Economics of coronary artery bypass grafting

1 reference

12 December 2020

Assessing health-related quality-of-life in individuals with haemophilia

1 reference

12 December 2020

Haemophilia prophylaxis in young patients--a long-term follow-up

1 reference

12 December 2020

Factor VIII pharmacokinetics: intermittent infusion versus continuous infusion

1 reference

12 December 2020

Dose requirement for replacement therapy in hemophilia A

1 reference

12 December 2020

Prophylactic use of factor VIII: an economic evaluation

1 reference

12 December 2020

Implantable venous access devices in children with hemophilia: a report of low infection rates

1 reference

12 December 2020

Elective total hip replacement: incidence, emergency readmission rate, and postoperative mortality

1 reference

12 December 2020

Hemophilia: yesterday, today, and tomorrow.

1 reference

12 December 2020

The successful removal of a bleeding intracranial tumour in a severe haemophiliac using an adjusted dose continuous infusion of monoclonal factor VIII.

1 reference

12 December 2020

Continuous infusion of intermediate-purity factor VIII in haemophilia A patients undergoing elective surgery

1 reference

12 December 2020

Multidose pharmacokinetics of factor IX: implications for dosing in prophylaxis

1 reference

12 December 2020

Episodic versus prophylactic infusions for hemophilia A: a cost-effectiveness analysis

1 reference

12 December 2020

Adjusted dose continuous infusion of factor VIII in patients with haemophilia A.

1 reference

12 December 2020

Central venous catheter-associated thrombosis in severe haemophilia

1 reference

12 December 2020

The use of continuous infusion of factor concentrates in the treatment of hemophilia

1 reference

12 December 2020

Orthopaedic surgery in hemophilia. 20 Years' experience in Sweden.

1 reference

12 December 2020

Use of central venous catheters in children with haemophilia: one haemophilia treatment centre experience

1 reference

12 December 2020

Variations in population health status: results from a United Kingdom national questionnaire survey

1 reference

12 December 2020

A prospective clinical trial of implantable central venous access in children with haemophilia

1 reference

12 December 2020

Mortality in patients with hemophilia. Changes in a Dutch population from 1986 to 1992 and 1973 to 1986.

1 reference

12 December 2020

Resource utilisation in haemophiliacs treated in Europe: results from the European Study on Socioeconomic Aspects of Haemophilia Care. The European Socioeconomic Study Group

1 reference

12 December 2020

Continuous infusion of factor concentrates: review of use in hemophilia A and demonstration of safety and efficacy in hemophilia B.

1 reference

12 December 2020

Family issues in continuous infusion therapy with factor VIII.

1 reference

12 December 2020

Successful treatment of acute subdural haemorrhage with continuous intravenous infusion of factor VIII in a 17 year old with haemophilia A.

1 reference

12 December 2020

Continuous infusion of factor VIII for surgery and major bleeding

1 reference

12 December 2020

Assessing the effectiveness and cost-effectiveness of prophylaxis against bleeding in patients with severe haemophilia and severe von Willebrand's disease

1 reference

12 December 2020

Prophylaxis and continuous infusion for hemophilia: can we afford it?

1 reference

12 December 2020

Continuous intravenous infusion of factor VIII in classic haemophilia

1 reference

12 December 2020

Socioeconomic impact of haemophilia care: results of a pilot study

1 reference

12 December 2020

Continuous infusion of factor IX concentrate to induce immune tolerance in two patients with haemophilia B.

1 reference

12 December 2020

Primary prophylaxis for individuals with severe haemophilia: how many hospital visits could treatment prevent?

1 reference

12 December 2020

GUIDELINES ON THERAPEUTIC PRODUCTS TO TREAT HAEMOPHILIA AND OTHER HEREDITARY COAGULATION DISORDERS.

1 reference

12 December 2020

Home therapy with continuous infusion of factor VIII after minor surgery or serious haemorrhage

1 reference

12 December 2020

Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.

1 reference

12 December 2020

A radiologic classification of hemophilic arthropathy

1 reference

12 December 2020

Continuous and intermittent infusion of coagulation factor concentrates in patients undergoing surgery: a single centre Australian experience

1 reference

12 December 2020

Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia

1 reference

12 December 2020

Use of central venous catheters in children with severe congenital coagulopathy

1 reference

12 December 2020

The effect of elective total hip replacement on health-related quality of life.

1 reference

12 December 2020

'Quick and clean': authoritative health technology assessment for local health care contracting

1 reference

12 December 2020

Primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses

1 reference

12 December 2020

Complications experienced with central venous catheters in children with congenital bleeding disorders

1 reference

12 December 2020

Prophylactic treatment in Sweden--overtreatment or optimal model?

1 reference

12 December 2020

The Markov process in medical prognosis.

1 reference

12 December 2020

Continuous infusion therapy in haemophilia

1 reference

12 December 2020

Central venous catheter infection in haemophiliacs undergoing prophylaxis or immune tolerance with clotting factor concentrate

1 reference

12 December 2020

Radiologic evaluation of prophylaxis in severe haemophilia

1 reference

12 December 2020

The feasibility of using concentrates containing factor IX for continuous infusion

1 reference

12 December 2020

Continuous infusion instead of bolus injections of factor concentrate?

1 reference

12 December 2020

Comparison of continuous and intermittent Factor VIII concentrate therapy in hemophilia A.

1 reference

12 December 2020

The use of the Port-A-Cath in children with haemophilia--a review

1 reference

12 December 2020

Efficacy of a high purity, chemically treated and nanofiltered factor IX concentrate for continuous infusion in haemophilia patients undergoing surgery

1 reference

12 December 2020

10.2165/00019053-200220110-00005

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

1012524589

0 references

1 reference

17 December 2017